1. Home
  2. EVC vs PBYI Comparison

EVC vs PBYI Comparison

Compare EVC & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$3.10

Market Cap

273.8M

Sector

Industrials

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$6.30

Market Cap

318.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVC
PBYI
Founded
1996
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.8M
318.0M
IPO Year
2000
2011

Fundamental Metrics

Financial Performance
Metric
EVC
PBYI
Price
$3.10
$6.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
392.2K
401.1K
Earning Date
03-05-2026
05-07-2026
Dividend Yield
6.49%
N/A
EPS Growth
47.59
N/A
EPS
N/A
0.61
Revenue
$536,034,000.00
$27,685,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.38
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$2.58
52 Week High
$3.68
$7.68

Technical Indicators

Market Signals
Indicator
EVC
PBYI
Relative Strength Index (RSI) 51.53 50.90
Support Level $2.85 $6.32
Resistance Level $3.20 $7.25
Average True Range (ATR) 0.14 0.20
MACD 0.00 0.04
Stochastic Oscillator 56.10 73.33

Price Performance

Historical Comparison
EVC
PBYI

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: